Literature DB >> 16101681

Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport.

Janet S May1, Brigitte D de Lima, Susanna Colaco, Philip G Stevenson.   

Abstract

The murine gamma-herpesvirus-68 (MHV-68) ORF27 encodes gp48, a type 2 transmembrane glycoprotein that contributes to intercellular viral spread. Gp48 is expressed on the surface of infected cells but is retained intracellularly after transfection. In this study, we show that the multimembrane spanning ORF58 gene product is both necessary and sufficient for gp48 to reach the cell surface. ORF58-deficient MHV-68 expressed ORF27 in normal amounts, but retained it in the endoplasmic reticulum (ER). Transfected ORF27 also remained in ER, whereas green fluorescent protein-tagged ORF58 localized to the ER and trans-Golgi network. When ORF27 and ORF58 were co-transfected, they formed a protein complex and reached the cell surface. Surprisingly, ORF58 rather than ORF27 mediated cell binding via a small extracellular loop. The heavily glycosylated ORF27 component of the complex may, therefore, act mainly to protect this loop against antibody. The interdependent transport of ORF27 and ORF58 transport ensures that such protection is always present.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16101681     DOI: 10.1111/j.1600-0854.2005.00316.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  17 in total

1.  The Major Envelope Glycoprotein of Murid Herpesvirus 4 Promotes Sexual Transmission.

Authors:  Caroline Zeippen; Justine Javaux; Xue Xiao; Marina Ledecq; Jan Mast; Frédéric Farnir; Alain Vanderplasschen; Philip Stevenson; Laurent Gillet
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Proteomic characterization of bovine herpesvirus 4 extracellular virions.

Authors:  Céline Lété; Leonor Palmeira; Baptiste Leroy; Jan Mast; Bénédicte Machiels; Ruddy Wattiez; Alain Vanderplasschen; Laurent Gillet
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

3.  The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein.

Authors:  Mindy Gore; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

4.  In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection.

Authors:  Laurent Gillet; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

5.  EBV-positive human sera contain antibodies against the EBV BMRF-2 protein.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Carl Sunshine; Sharof M Tugizov
Journal:  Virology       Date:  2009-08-20       Impact factor: 3.616

6.  EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Jennifer Berline; Sharof M Tugizov
Journal:  Virology       Date:  2009-04-24       Impact factor: 3.616

7.  The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.

Authors:  Jianqiao Xiao; Joel M Palefsky; Rossana Herrera; Jennifer Berline; Sharof M Tugizov
Journal:  Virology       Date:  2007-10-22       Impact factor: 3.616

8.  Evidence for a multiprotein gamma-2 herpesvirus entry complex.

Authors:  Laurent Gillet; Philip G Stevenson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

9.  Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4.

Authors:  Bruno Frederico; Ricardo Milho; Janet S May; Laurent Gillet; Philip G Stevenson
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

10.  In vivo imaging of murid herpesvirus-4 infection.

Authors:  Ricardo Milho; Christopher M Smith; Sofia Marques; Marta Alenquer; Janet S May; Laurent Gillet; Miguel Gaspar; Stacey Efstathiou; J Pedro Simas; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.